Advances in paediatric gastroenterology

Paul K H Tam1, Patrick H Y Chung1, Shawn D St Peter2

  • 1Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Lancet (London, England)
|September 14, 2017
PubMed

Insights

Minimally invasive surgery shows promise in pediatric gastrointestinal surgery, especially for common conditions. Further research is needed for rare neonatal disorders and long-term care for survivors.

Area of Science:

  • Pediatric Surgery
  • Gastrointestinal Surgery
  • Neonatal Surgery

Background:

  • Minimally invasive surgery (MIS) is advancing in pediatric gastrointestinal surgery.
  • MIS benefits are well-established for common conditions like appendicitis.
  • Challenges exist in applying MIS to rare neonatal gastrointestinal disorders due to limited clinical trial data.

Purpose of the Study:

  • To review recent developments in pediatric gastrointestinal surgery.
  • To highlight the need for clinical evidence in rare neonatal conditions.
  • To discuss future research directions, including genetics and stem-cell therapy.

Main Methods:

  • Review of current literature on pediatric and neonatal gastrointestinal surgery.
  • Analysis of evidence supporting minimally invasive approaches.
  • Discussion of challenges and future research needs for rare diseases.

Main Results:

  • Minimally invasive surgery is supported by strong evidence for common pediatric gastrointestinal issues.
  • Clinical trials for rare neonatal disorders are difficult but crucial.
  • Specialization and collaboration have improved outcomes for conditions like biliary atresia.

Conclusions:

  • High-quality evidence is essential for advancing pediatric and neonatal gastrointestinal surgery.
  • Future research should focus on rare diseases, long-term sequelae, and underlying pathogenesis.
  • Genetics and stem-cell therapy offer potential for conditions like Hirschsprung's disease.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.3K
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.0K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
736